Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: Trial of Multi-Strain Probiotic Supplementation (Hexbio®) in Malaysian Patients With Drug-Resistant Epilepsy (ProbE) [NA]
Clinical trial update for Hexbio, a multi-strain probiotic, being studied in Malaysian patients with drug-resistant epilepsy; the study is c…
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: Levetiracetam Versus Phenobarbital in Benzodiazepines Unresponsive Paediatric Prolonged Seizures [NA]
This clinical trial in Myanmar is recruiting to compare levetiracetam with phenobarbital for pediatric seizures unresponsive to benzodiazepi…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: Effect of Vitamin D3 Supplementation on Brain Waves in Male Epileptic Patients With Hypovitaminosis D [NA]
A clinical trial is evaluating whether vitamin D3 supplementation influences brain wave activity in male epilepsy patients with vitamin D de…
-
CLINICAL_TRIALS research · 2025-07-30Clinical Trial Update: Risk Factors for Sudden Unexplained Death in Epilepsy
This clinical trial from NYU Langone Health is investigating risk factors for Sudden Unexpected Death in Epilepsy (SUDEP) and is currently r…
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: Navigation and Free Recall in Chronically Implanted Humans [NA]
This clinical trial update reports on navigation and free recall in chronically implanted humans, in a study involving epilepsy patients. Th…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-29Clinical Trial Update: A Study to Test the Safety/ Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects >=16 Years of Age With Partial Seizures With or Without Secondary Generalization [Phase 3]
A Phase 3 trial evaluating brivaracetam as adjunctive therapy in subjects aged 16 and older with partial seizures with or without secondary …
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: Effects of Podcast Education on Medication Perception, Stigma Level, and Epilepsy Self-management in Epilepsy Patients [NA]
This clinical trial update reports a completed study evaluating whether podcast education affects medication perception, stigma levels, and …
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: NYU Epilepsy Self-Management Study [NA]
A NYU Langone Health-sponsored epilepsy self-management clinical trial is listed as not yet recruiting.
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Effect of Vitamin D3 Supplementation on Cardiac Autonomic Nerve Function in Male Epileptic Patients With Hypovitaminosis D [NA]
A recruiting clinical trial is evaluating whether vitamin D3 supplementation improves cardiac autonomic nerve function in male epilepsy pati…
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults [Phase 3]
Phase 3 clinical trial evaluating carisbamate as adjunctive treatment for seizures in Lennox-Gastaut syndrome; recruitment is ongoing.
-
FDA approval · 2025-07-23FDA Approved: TOPIRAMATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Topiramate from Aurobindo Pharma Limited under an existing ANDA.
-
FDA approval · 2025-07-23FDA Approved: GABAPENTIN — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved a supplemental application for gabapentin from Camber Pharmaceuticals, enabling the generic version to be marketed.
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Oscillatory Activity in Basal Ganglia Circuits During Normal and Pathological Movement [NA]
This clinical trial update describes a study examining oscillatory activity in basal ganglia circuits during normal and pathological movemen…
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: Investigation of the Effects of Pilates Training in Patients With Drug-Resistant Epilepsy [NA]
A completed clinical trial evaluated the effects of Pilates training on epilepsy-related outcomes in patients with drug-resistant epilepsy, …
-
FDA approval · 2025-07-21FDA Approved: LACOSAMIDE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for lacosamide filed by Zydus Pharmaceuticals USA Inc., updating the product labeling. This action c…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Temporally Interfering Electric Field Stimulation in the Treatment of Epilepsy [NA]
A UC Davis–led clinical trial is evaluating temporally interfering electric field stimulation as a treatment for epilepsy and is currently e…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients [NA]
This clinical trial update concerns a study investigating prefrontal and medial temporal neuronal responses to algorithmic cognitive variabl…
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: Neural Computations of Goal-directed Decision-making [NA]
This clinical trial update describes research on neural computations underlying goal-directed decision-making in individuals with intractabl…
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: WISE Cortical Strip for Intraoperative Neurophysiological Monitoring [NA]
The clinical trial NCT03731455 evaluating the WISE Cortical Strip for intraoperative neurophysiological monitoring has completed. The sponso…
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: Amygdala Memory Enhancement [NA]
A clinical trial investigating amygdala memory enhancement is currently recruiting. The trial targets conditions including epilepsy, memory …
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: A Double Blind, Randomized, Cross-over Study Examining the Suppression of the Photoparoxysmal EEG Response With NPT 2042 [Phase 1]
Phase 1 cross-over trial evaluating whether NPT 2042 suppresses the photoparoxysmal EEG response in photosensitive epilepsy has completed, w…
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: Clinical Applicantion of Multi-Tracer PET/MR Imaging in Neurological Disorders/Disease
A clinical trial update from Xuanwu Hospital Beijing describing the recruitment of a multi-tracer PET/MR imaging study for neurological diso…
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: Non-Helium Magnetoencephalography in Pediatric Refractory Epilepsy
A clinical trial evaluating non-helium magnetoencephalography for pediatric refractory epilepsy is currently recruiting at Guangzhou Women a…
-
FDA approval · 2025-07-11FDA Approved: OXCARBAZEPINE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved a generic oxcarbazepine tablet from Macleods Pharmaceuticals Limited under an Original Application (ANDA).
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy [NA]
A clinical trial update studying ketogenic therapy and its effects on electrical and metabolic abnormalities in epilepsy, currently recruiti…